97 related articles for article (PubMed ID: 8606751)
1. Oral peptide delivery: improving the systemic availability of small peptides and enkephalin analogs.
Lee HJ; Amidon GL
NIDA Res Monogr; 1995; 154():86-106. PubMed ID: 8606751
[No Abstract] [Full Text] [Related]
2. Oral biodrug delivery using cell-penetrating peptide.
Khafagy el-S; Morishita M
Adv Drug Deliv Rev; 2012 May; 64(6):531-9. PubMed ID: 22245080
[TBL] [Abstract][Full Text] [Related]
3. Microemulsions for improved peptide absorption from the gastrointestinal tract.
Ritschel WA
Methods Find Exp Clin Pharmacol; 1991 Apr; 13(3):205-20. PubMed ID: 2051845
[TBL] [Abstract][Full Text] [Related]
4. Intestinal metabolism and absorption of cholecystokinin analogs in rats.
Su SF; Amidon GL; Lee HJ
Biochem Biophys Res Commun; 2002 Apr; 292(3):632-8. PubMed ID: 11922613
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional matrices for oral peptide delivery.
Bernkop-Schnürch A; Walker G
Crit Rev Ther Drug Carrier Syst; 2001; 18(5):459-501. PubMed ID: 11763498
[TBL] [Abstract][Full Text] [Related]
6. [Methodologies for regulation of intestinal absorption of biologically active peptides].
Fujita T; Muranishi S
Nihon Rinsho; 1998 Mar; 56(3):589-94. PubMed ID: 9549341
[TBL] [Abstract][Full Text] [Related]
7. Delivery systems for biopharmaceuticals.
Davis SS
J Pharm Pharmacol; 1992 Feb; 44 Suppl 1():186-90. PubMed ID: 1348281
[No Abstract] [Full Text] [Related]
8. Correlation of in vitro and in vivo models for the oral absorption of peptide drugs.
Föger F; Kopf A; Loretz B; Albrecht K; Bernkop-Schnürch A
Amino Acids; 2008 Jun; 35(1):233-41. PubMed ID: 17726639
[TBL] [Abstract][Full Text] [Related]
9. The effect of enzyme inhibitor and absorption site following [D-ala2, D-leu5]enkephalin oral administration in rats.
Lee HJ; Amidon GL
Biopharm Drug Dispos; 2002 May; 23(4):131-41. PubMed ID: 12015787
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs.
Takeuchi H; Matsui Y; Sugihara H; Yamamoto H; Kawashima Y
Int J Pharm; 2005 Oct; 303(1-2):160-70. PubMed ID: 16125348
[TBL] [Abstract][Full Text] [Related]
11. [Site-specific drug delivery systems II. Buccal delivery systems].
Szente V; Zelkó R
Acta Pharm Hung; 2007; 77(4):217-22. PubMed ID: 18290541
[TBL] [Abstract][Full Text] [Related]
12. Modulation of intestinal permeability: an innovative method of oral drug delivery for the treatment of inherited and acquired human diseases.
Fasano A
Mol Genet Metab; 1998 May; 64(1):12-8. PubMed ID: 9682213
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in cell-penetrating, non-peptide molecular carriers.
Chung SK; Maiti KK; Lee WS
Int J Pharm; 2008 Apr; 354(1-2):16-22. PubMed ID: 17890027
[TBL] [Abstract][Full Text] [Related]
14. Emerging strategies for the transdermal delivery of peptide and protein drugs.
Schuetz YB; Naik A; Guy RH; Kalia YN
Expert Opin Drug Deliv; 2005 May; 2(3):533-48. PubMed ID: 16296773
[TBL] [Abstract][Full Text] [Related]
15. Systemic delivery of peptides and proteins across absorptive mucosae.
Sayani AP; Chien YW
Crit Rev Ther Drug Carrier Syst; 1996; 13(1-2):85-184. PubMed ID: 8853960
[TBL] [Abstract][Full Text] [Related]
16. Enzymatic barriers to peptide and protein absorption.
Lee VH
Crit Rev Ther Drug Carrier Syst; 1988; 5(2):69-97. PubMed ID: 3052875
[TBL] [Abstract][Full Text] [Related]
17. Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials.
Aguirre TA; Teijeiro-Osorio D; Rosa M; Coulter IS; Alonso MJ; Brayden DJ
Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):223-241. PubMed ID: 26921819
[TBL] [Abstract][Full Text] [Related]
18. Advances in oral drug delivery: improved bioavailability of poorly absorbed drugs by tissue and cellular optimization. Preface.
Morishita M; Peppas NA
Adv Drug Deliv Rev; 2012 May; 64(6):479. PubMed ID: 22388003
[No Abstract] [Full Text] [Related]
19. Effects of absorption promoters on insulin absorption through colon-targeted delivery.
Katsuma M; Watanabe S; Kawai H; Takemura S; Sako K
Int J Pharm; 2006 Jan; 307(2):156-62. PubMed ID: 16289574
[TBL] [Abstract][Full Text] [Related]
20. Delivery aspects of small peptides and substrates for peptide transporters.
Steffansen B; Nielsen CU; Frokjaer S
Eur J Pharm Biopharm; 2005 Jul; 60(2):241-5. PubMed ID: 15908190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
